|
|
 Previous Article | Table of Contents | Next Article 
Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic
progenitor cells
C Peschel, WE Paul, J Ohara and I Green
B cell stimulatory factor-1 (BSF-1)/Interleukin 4 (IL 4) is a T cell
product originally characterized on the basis of its actions on B
lymphocytes. Recently it has been reported that BSF-1 activates T cell and
mast cell lines. We now provide evidence that BSF-1, purified to
homogeneity, also has a broad spectrum of activity on hematopoietic
progenitor cells (HPC). However, like its action on B cells, prolierative
effects were only observed when BSF-1 was combined with an additional
factor. Thus BSF-1, in costimulation with recombinant G-CSF, enhances the
proliferation of granulocyte-macrophage progenitor cells (CFU-GM). BSF-1
increases the proliferation of CFU-e in the presence of recombinant
erythropoietin (rEPO). Furthermore, BSF-1 induces, together with rEPO,
colony formation by primitive erythroid (BFU-e) and multipotent (CFU-mix)
progenitor cells comparable to that observed with rEPO and interleukin 3
(IL 3). BSF-1 is also active as a megakaryocyte colony-stimulating factor;
in combination with recombinant interleukin 1, rEPO or the supernatant of
the T cell hybridoma FS7-20.6.18, BSF-1 induces megakaryocyte colony
formation (CFU-Mk). The same factors that synergize with BSF-1 also enhance
CFU-Mk proliferation induced by IL 3. Although the precise mechanisms of
action of BSF-1 on HPC is not yet known, we propose that BSF-1 represents
an activation factor for HPC and prepares the progenitor cells to respond
to specific growth or differentiation factors.
Volume 70,
Issue 1,
pp. 254-263,
07/01/1987
Copyright © 1987 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Thawani, M. Tam, and M. M. Stevenson
STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia
Haematologica,
February 1, 2009;
94(2):
195 - 204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Bunting, W.-M. Yu, H. L. Bradley, E. Haviernikova, A. E. Kelly-Welch, A. D. Keegan, and C.-K. Qu
Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression
J. Leukoc. Biol.,
August 1, 2004;
76(2):
484 - 490.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-T. Brenne, T. Baade Ro, A. Waage, A. Sundan, M. Borset, and H. Hjorth-Hansen
Interleukin-21 is a growth and survival factor for human myeloma cells
Blood,
May 15, 2002;
99(10):
3756 - 3762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Basak, A. Harui, M. Stolina, S. Sharma, K. Mitani, S. M. Dubinett, and M. D. Roth
Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4
Blood,
April 15, 2002;
99(8):
2869 - 2879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Oetzel, T. Jonuleit, A. Gotz, H. van der Kuip, H. Michels, J. Duyster, M. Hallek, and W. E. Aulitzky
The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X
Clin. Cancer Res.,
May 1, 2000;
6(5):
1958 - 1968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bruno, S. K. Horrigan, D. Van Den Berg, E. Rozler, P. R. Fitting, S. T. Moss, C. Westbrook, and R. Hoffman
The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-beta on Human Hematopoiesis
Blood,
March 15, 1998;
91(6):
1917 - 1923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Peters, P. Schirmacher, J. Goldschmitt, M. Odenthal, C. Peschel, E. Fattori, G. Ciliberto, H.-P. Dienes, K.-H. M. z. Buschenfelde, and S. Rose-John
Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6-sIL-6R Double Transgenic Mice
J. Exp. Med.,
February 17, 1997;
185(4):
755 - 766.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Gossett, T. A. Barbolt, J. B. Cornacoff, D. J. Zelinger, and J. H. Dean
Clinical Pathologic Alterations Associated with Subcutaneous Administration of Recombinant Human Interleukin-4 to Cynomolgus Monkeys
Toxicol Pathol,
January 1, 1993;
21(1):
46 - 53.
[Abstract]
[PDF]
|
|
|
|
|
